Keyphrases
2-methoxyestradiol
36%
Acute Myeloid Leukemia
18%
ADAR1
20%
Adenosine Deaminase Acting on RNA
21%
Alternative Splicing
26%
Antibody Targeting
20%
Apoptosis
59%
Blast Crisis
41%
Breast Cancer Cell Lines
36%
Caspase-dependent
18%
Caspase-independent
18%
Cellular Dormancy
18%
Chronic Myeloid Leukemia
33%
Clinical Safety
18%
Estrogen Metabolites
20%
Fibroids
37%
Gene Expression
25%
Gli2
18%
Gynecological Cancer
18%
Healthy Cells
18%
HMG-CoA Reductase
18%
Human Endometrium
22%
Human Leukemia
38%
Hydrophilic Statin
18%
Induced Apoptosis
25%
Leiomyoma
23%
Leukemia Stem Cells
100%
Lipophilic
18%
Monoclonal Antibody
22%
Nuclear Expression
18%
Ovarian Cancer Cells
18%
Procoagulant Activity
18%
Progesterone
40%
Receptor 1
22%
Reproductive Tract
23%
RNA Splicing
18%
Self-renewal
21%
Smooth muscle Cells
20%
Splice Isoforms
31%
Splicing Modulation
18%
Stem Cell Maintenance
26%
Stem Cell Self-renewal
41%
Stem Cells
22%
Telomerase Expression
18%
Tissue Factor
23%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
29%
Tumor Necrosis Factor-α
18%
Tyrosine Kinase Inhibition
20%
Uterine Fibroids
36%
ZR-75-1
18%
Biochemistry, Genetics and Molecular Biology
2-Methoxyestradiol
36%
Adenosine Deaminase
21%
Alternative Splicing
26%
Biogenesis
18%
Cancer Cell
62%
Caspase
23%
Catenin
18%
CD34
12%
CD44
9%
Cell Cycle
12%
Cell Proliferation
6%
Cell Regeneration
18%
Coculture
10%
Colon
18%
CYR61
12%
Dormancy
18%
Downregulation
9%
Drive
18%
Endometrium
18%
Epidermal Growth Factor
18%
Exon
6%
Gene Expression
7%
GLI2
18%
Isoform
37%
Janus Kinase
6%
Metabolite
20%
Monoclonal Antibody
7%
Mouse Model
11%
Myeloid
69%
Oligonucleotide Microarrays
6%
Progesterone
18%
Quantitative Reverse Transcription Polymerase Chain Reaction
17%
Receptor Tyrosine Kinase
42%
Reprogramming
27%
Retinoblastoma
18%
Revertant
18%
RNA
11%
RNA Editing
8%
RNA Sequence
15%
RNA Splicing
18%
Signal Transduction
21%
Small Hairpin RNA
7%
Stem Cell
86%
Stem Cell Self-Renewal
41%
T Cell
18%
Tumor Necrosis Factor
25%
Tyrosine
18%
Tyrosine Kinase
24%
Tyrosine Kinase Inhibitor
5%
Wild Type
5%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
18%
Angioleiomyoma
21%
B Cell
6%
B-Cell Chronic Lymphocytic Leukemia
12%
Bioluminescence
5%
Blast Cell Crisis
13%
Breast Cancer
10%
Breast Cancer Cell Line
18%
Cell Cycle
11%
Cell Regeneration
18%
Cell Surface
6%
Cervix
9%
Chronic Myelogenous Leukemia
18%
Clinical Study
6%
CYR61
9%
Death Receptor
9%
Dormancy
18%
Endometrium
6%
Fallopian Tube
9%
Gene Expression
27%
In Vitro
18%
Leukemia
50%
Leukemia Cell
6%
Malignant Neoplasm
18%
Monoclonal Antibody
20%
Myometrium
13%
Oncology
18%
Procoagulant
18%
Progesterone
21%
Programmed Cell Death
18%
Protein Tyrosine Kinase
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
6%
Receptor
22%
Receptor Tyrosine Kinase Like Orphan Receptor
6%
RNA Editing
9%
Stem Cell
27%
Stem Cell Self-Renewal
6%
Targeted Therapy
6%
Thromboplastin
23%
Tibolone
18%
Transplantation
11%
Uterine Cancer
10%
Uterine Fibroid
36%
Xenograft
20%